The Omicron variant from Covid-19 family is still prevalence while another variant called XBB is becoming a threat for people. Nevertheless, this virus is still changing into several subvariants, each with unique mutations. The COVID viral sub lineage BA. contains the Omicron subvariant XBB, which is beginning to attract attention on a global scale. WHO classifies XBB as a component of Omicron variant. It has been found that because XBB and its sub lineages are not significantly different from other Omicron sub lineages, they do not require a new label or to be recognised as a new variety of concern.
Prevalence of XBB
XBB has been identified as of October 2022 in almost 35 nations, including the US. A recent spike in COVID 19 cases was caused by the subvariant, which has also been linked to numerous cases in countries such as Australia, South Korea, and India. In Singapore, where vaccination rates are high, COVID instances are also rising, and XBB may be more contagious.
Reinfection Risk
Even if you have had COVID, there is a chance that you could contract the XBB variation again, suggesting that there may be a larger risk of reinfection with this strain. Before the Omicron period, people who were reinfected with XBB first developed COVID. To be certain, however, as to whether or not XBB escapes Omicron immunity, we need to see more evidence. Although there is currently no proof that XBB will be more problematic and severe compared to the other subvariants, we still need to remain vigilant and monitor the number of new infections.
Severity of XBB Variant
There are currently no indications that XBB contributes to more severe COVID sickness. However, it is important to remember that not simply the COVID variation a person contracts determines how unwell they will become if they contract it.
Vaccines and Treatments for XBB
It is anticipated that the drugs we now use to treat COVID will continue work against the circulating variations and XBB. Researchers warned that it might not be successful, though. One of the most antibody-evasive mutations yet discovered, XBB exhibits significant treatment resistance to antibodies. Health organisations from all around the world are attentively monitoring the XBB variety and gathering as much information as they can about it. The best action you can take right now to safeguard yourself against COVID is to receive a bivalent booster when you are qualified. The new injections offer superior defence against the Omicron version over the older monovalent booster shots.
